⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Official Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine With or Without Birinapant With a Single Arm Open-Label Run-In Phase in Subjects With Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Study ID: NCT02147873

Study Description

Brief Summary: This is a randomized double blind placebo controlled study of azacitidine with or without birinapant in subjects with higher risk Myelodysplastic syndrome, secondary MDS or myelomonocytic leukemia (CMMoL) who are naïve, to azacitidine therapy. Pre-clinical and mechanistic studies support that azacitidine may modulate pathways that enable birinapant-mediated anti-tumor activity.

Detailed Description: This is a randomized double blind placebo controlled study of azacitidine with or without birinapant in subjects with higher risk Myelodysplastic syndrome, secondary MDS or myelomonocytic leukemia (CMMoL) The primary purpose of this study is : -To compare the relative effect of azacitidine plus birinapant versus azacitidine plus placebo on response rate in patients with higher-risk MDS, secondary MDS or CMMoL. The secondary purpose of this study is to compare effect of azacitidine plus birinapant relative to azacitidine with placebo on: * Hematologic improvement * Relapse free survival * Time to respond * Change in transfusion requirements * Duration of response * Overall survival * Adverse events The exploratory objective of this study is to assess exploratory translational biomarkers for antitumor effects.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Palo Verde Hematology Oncology, Glendale, Arizona, United States

Arizona Center for Cancer Care, Glendale, Arizona, United States

Mayo Clinic, Scottsdale, Arizona, United States

Arizona Oncology Associates, Tucson, Arizona, United States

Ronald Reagan UCLA Medical Center, Los Angeles, California, United States

North County Oncology, Oceanside, California, United States

Desert Hematology Oncology Medical Group, Rancho Mirage, California, United States

Stanford Hospital and Clinics, Stanford, California, United States

Wellness Oncology & Hematology, West Hills, California, United States

Colorado Blood Cancer Institute, Denver, Colorado, United States

Cancer Specialists of North Florida, Jacksonville, Florida, United States

Mayo Clinic Jacksonville, Jacksonville, Florida, United States

Hematology Oncology Associates of the Treasure Coast, Port St. Lucie, Florida, United States

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States

Bond Clinic PA, Winter Haven, Florida, United States

Loyola University Medical Center, Maywood, Illinois, United States

Simmons Cancer Institute at Southern Illinois University, Springfield, Illinois, United States

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

University of Louisville Hospital/James Graham Brown Cancer Center, Louisville, Kentucky, United States

Tulane Medical Center, New Orleans, Louisiana, United States

University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, United States

University of Massachusetts Worcester, Worcester, Massachusetts, United States

St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States

New Jersey Hematology Oncology Associates, Brick, New Jersey, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Montefiore Medical Center, Bronx, New York, United States

North Shore Hematology Oncology Associates, East Setauket, New York, United States

Monter Cancer Center, Lake Success, New York, United States

Columbia University Medical Center, New York, New York, United States

Weill Cornell Medical College - New York-Presbyterian Hospital, New York, New York, United States

Duke University Medical Center, Durham, North Carolina, United States

Gabrail Cancer Center Research, Canton, Ohio, United States

Oncology Hematology Care, Inc., Cincinnati, Ohio, United States

Oregon Health and Sciences University, Portland, Oregon, United States

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States

Carolina Blood and Cancer Care Associates, P.A., Rock Hill, South Carolina, United States

Tennessee Oncology, Chattanooga, Tennessee, United States

Tennessee Oncology, Nashville, Tennessee, United States

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Tyler Hematology Oncology PA, Tyler, Texas, United States

Utah Cancer Specialists, Salt Lake City, Utah, United States

University of Utah, Huntsman Cancer Hospital, Salt Lake City, Utah, United States

Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Seattle Cancer Care Alliance, Seattle, Washington, United States

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Westmead Hospital, Westmead, New South Wales, Australia

Metro South Health, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Royal Hobart Hospital, Hobart, Tasmania, Australia

Austin Health, Heidelberg, Victoria, Australia

Cabrini Hospital, Malvern, Victoria, Australia

The Alfred, Melbourne, Victoria, Australia

Border Medical Oncology, Wodonga, Victoria, Australia

Perth Blood Institute, Nedlands, Western Australia, Australia

Klinikum Rechts der Isar, Technischen Universitat Munchen, Munchen, Bayern, Germany

Klinikum der Ludwig-Maximilians-Universitat Munchen, Munich, Bayern, Germany

Marien Hospital Dusseldorf, Dusseldorf, Nordrhein-Westfalen, Germany

University Hospital of Cologne, Cologne, North Rhine Westphalia, Germany

University Hospital Halle, Halle (Saale), Saxony-Anhalt, Germany

Universitatsklinikum Essen, Essen, , Germany

Medizinische Hochschule Hannover, Hannover, , Germany

Medizinische Universitatsklinik Heidelberg, Heidelberg, , Germany

Universitatsklinikum Wurzburg, Wurzburg, , Germany

Hospital Universitario Severo Ochoa, Leganes, Madrid, Spain

Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain

Clinica Universidad de Navarra, Pamplona, Navarra, Spain

Hospital Universitario de Canarias, La Laguna, S/C Tenerife, Spain

Hospital Germans Trias I Pujol, Badalona, , Spain

Hospital University Reina Sofia, Cordoba, , Spain

Hospital Universitario Gregorio Maranon, Madrid, , Spain

MD Anderson Cancer Center, Madrid, , Spain

Hospital Universitario de Salamanca, Salamanca, , Spain

Complejo Hospitalario Virgen de la Salud, Toledo, , Spain

Hospital Clinico Universitario de Valencia, Valencia, , Spain

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: